Do breast cancer risk factors differ among those who do and do not undertake mammography screening?

Journal of Medical Screening

Volumn 20, Issue 4, 2013, Pages 208-219

  Beckmann, Kerri R ^a   Roder, David M ^b   Hiller, Janet E ^c   Farshid, Gelareh ^d   Lynch, Ohn W ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^d Port Phillip Prison   (Australia)

Author keywords

Breast neoplasm; Mammographic screening; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST NEOPLASM; BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHIC SCREENING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RISK FACTOR; STATISTICS; VERY ELDERLY;

BREAST NEOPLASM; MAMMOGRAPHIC SCREENING; RISK FACTORS;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RISK FACTORS;

EID: 84901296079     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141313510293     Document Type: Article

References (40)

1. Schueler KM, Chu PW, Smith-Bindman R. Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health 2008;17(9):1477-98.
2. von Euler-Chelpin M, Olsen AH, Njor S, et al. Socio-demographic determinants of participation in mammography screening. Int J Cancer 2008;122(2):418-23.
3. Smith ML, Hochhalter AK, Ahn S, et al. Utilization of screening mammography among middle-aged and older women. J Womens Health 2011;20(11):1619-26.
4. Vernon SW, Laville EA, Jackson GL. Participation in breast screening programs: a review. Soc Sci Med 1990;30(10):1107-18.
5. Meissner HI, Breen N, Taubman ML, et al. Which women aren't getting mammograms and why? (United States). Cancer Causes Control 2007;18(1):61-70.
6. Paci E, Duffy S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005;7(6):266-70.
7. Duffy S, Cuzick J, Tabar L, et al. Correcting for non-compliance in case-control studies to evaluate cancer screening programmes. Journal of the Royal Statistical Society Series C (Applied Stastistics) 2002;51(2):235-43.
8. Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 2006;42(6):401-8.
9. McCaul KD, Branstetter AD, Schroeder DM, et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health psychology: official journal of the Division of Health Psychology, American Psychological Association 1996;15(6):423-9.
10. Kim J, Jang SN. Socioeconomic disparities in breast cancer screening among US women: trends from 2000 to 2005. Journal of preventive medicine and public health 2008;41(3):186-94.
11. Kjellen M, von Euler-Chelpin M. Socioeconomic status as determinant for participation in mammography screening: assessing the difference between using women's own versus their partner's. International journal of public health 2010;55(3):209-15.
12. Zackrisson S, Andersson I, Manjer J, et al. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108(5):754-60.
13. dos Santos Silva I, Beral V. Socioeconomic differences in reproductive behaviour. In: Kogevinas M, Pearce N, Susser M, Boffett P, editors. Social Inequalities and Cancer. Lyon International Agency for Research on Cancer; 1997.
14. Lagerlund M, Sontrop JM, Zackrisson S. Do reproductive and hormonal risk factors for breast cancer associate with attendance at mammography screening? Cancer Causes Control 2013 Epub 2013/06/06.
15. Lopez-de-Andres A, Martin-Lopez R, Hernandez-Barrera V, et al. Predictors of breast and cervical cancer screening in a Spanish metropolitan area. J Womens Health 2010;19(9):1675-81.
16. Coughlin SS, Uhler RJ, Hall HI, et al. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Preventing chronic disease 2004;1(1):A04.
17. Miles A, Cockburn J, Smith RA, et al. A perspective from countries using organized screening programs. Cancer 2004;101(5 Suppl): 1201-13.
18. Walsh B, Silles M, O'Neill C. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15. Health policy 2011;101(3):269-76.
19. Palencia L, Espelt A, Rodriguez-Sanz M, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol 2010;39(3):757-65.
20. BreastScreen SA. The impact of BreastScreen SA, 20 year report 1989-2008: with trend data for 1989-2004. Adelaide, Government of South Australia 2010.
21. Wilson DH, Wakefield M, Taylor AW. The South Australian Health Omibus Survey. Health Promotion J Aust 1992;2:47-9.
22. Australian Bureau of Statistics. Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), 2006 Canberra ABS; 2008.
23. The IPAQ Group. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-Short and long forms. 2005 November 2005 [cited; Available from: www.ipaq.ki.se/scoring.pdf
24. World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR, 2007.
25. Australian Bureau of Statistics. 3101.0-Australian Demographic Statisitics, June 2012. Canberra: ABS, 2012.
26. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30(4):377-99.
27. von Hippel PT. Regression with missing Ys: An improved strategy for analyzing multiply imputed data. Sociological Methodology 2007;37(1):83-117.
28. Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999;91(21):1829-46.
29. Pfeiffer RM, Park Y, Kreimer AR, et al. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Medicine 2013;10(7):e1001492.
30. StataCorp. Stata Statisitical Software: Release 12. College Station. TX: StatCorp LP, 2010.
31. Wee CC, McCarthy EP, Davis RB, et al. Obesity and breast cancer screening. Journal of general internal medicine 2004;19(4):324-31.
32. Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. Journal of women's health & gender-based medicine 2001;10(5):463-70.
33. Berz D, Sikov W, Colvin G, et al. 'Weighing in' on screening mammography. Breast Cancer Res Treat 2009;114(3):569-74.
34. Roder D, Houssami N, Farshid G, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108(3):409-16.
35. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350(9084):1047-59.
36. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152(6):514-27.
37. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353(3):229-37.
38. Arnold M, Razum O, Coebergh JW. Cancer risk diversity in non-western migrants to Europe: An overview of the literature. Eur J Cancer 2010;46(14):2647-59.
39. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 2013;137(3):869-82.
40. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 2011;8(11):669-76.